Every earnings call for OSELDEVICE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
OSELDEVICE · 3 transcripts · Healthcare · latest Q4 FY26OSEL Devices has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹293 cr (+57% YoY); EBITDA ₹53 cr (+58% YoY); EBITDA Margin 18.2%. Revenue of ₹292.7 crores, up 56.9% YoY.
Read full transcript & analysisHearing aids contributed ~35% of revenue with 30-35% gross margins.
Read full transcript & analysisFY25 EBITDA Margin 18.0%. H2 FY25 revenue estimated at ₹99 crores, with Q4 FY25 revenue around ₹45-50 crores.
Read full transcript & analysis